• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. VENASEAL; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. VENASEAL; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 05/06/2022
Event Type  Injury  
Event Description
Had minor surgery to remove varicose vein on (b)(6) 2022.The vascular surgeon used a procedure called venaseal which is the injection of cyanoacrylate glue.I had an allergic reaction to the glue.Since (b)(6) 2022 to present ((b)(6) 2022) i have had 2 minor surgeries, 2 major surgeries, and two hospitalizations.All lab data from the above mentioned procedures will be made available upon request.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENASEAL
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC, INC.
MDR Report Key14934579
MDR Text Key295429054
Report NumberMW5110685
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/05/2022
Patient Sequence Number1
Treatment
CALCIUM TABLETS; DUPIXENT FOR ASTHMA; SINGULAIR FOR ALLERGIES ; VITAMIN D
Patient Outcome(s) Required Intervention; Other; Hospitalization;
Patient Age58 YR
Patient SexFemale
Patient Weight89 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-